News

  • EndoC-BH1 Human Beta Cells for HTS and Diabetes Drug Discovery

    03/22/2018

    In the most comprehensive independent evaluation of the human beta cell line EndoC-βH1 conducted to date, a publication co-authored by lead pharmacologists and drug development experts at Novo Nordisk revealed EndoC-βH1 to be a very valuable and highly relevant tool for studying Diabetes. » Read more


  • Univercell-Biosolutions launches center of expertise with industrial and standardized approach to hiPSc cell line production

    07/8/2015

    The center of expertise offers quality control and process management applied to a large panel of standardized products based on the Pluri-one® platform » Read more


  • Acquisition of iPS Cell Patent license from iPS Academia Japan

    02/15/2011

    Non-exclusive worldwide licence will enable Univercell-Biosolutions to produce human cardiomyocytes for efficacy and toxicology testing » Read more